Medicine for itching in kidney dialysis patients
This study tests a medicine called nalfurafine to see if it can reduce severe itching that many people on dialysis have. It will compare the medicine to standard care to find out if it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are on dialysis two times a week for more than 6 months and feel stable during dialysis.
- You are between 18 and 65 years old.
- You have moderate to severe itching that has not been helped by standard treatment for at least 2 weeks.
- You have no other major health problems like cancer, active infection, liver disease, or a primary skin disease.
- You are not currently using phototherapy (light therapy) or acupuncture.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether hand massage can help reduce the chronic itching that many people on dialysis experience. It compares two groups to see if massage provides relief and improves quality of life.
This trial tests a new tablet called nalfurafine to help reduce severe itching that happens in people on regular kidney dialysis. If you've had itching for a while despite trying other treatments, this study may help you and contribute to better options for dialysis patients.
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.
This trial tests a medication called difelikefalin to relieve severe itching in people on long-term kidney dialysis. Many dialysis patients experience persistent itching that affects their quality of life, and this study explores whether this drug can help.
This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.
Hear when a new End Stage Renal Disease on Dialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.